Exagen/$XGN
1D1W1MYTD1Y5YMAX
About Exagen
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.
- Ticker
- $XGN
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 218
- Headquarters
- Vista, United States
- Website
- www.exagen.com
Exagen Metrics
BasicAdvanced
$184M
-
-$0.80
2.03
-
Price and volume
Market cap
$184M
Beta
2.03
52-week high
$12.23
52-week low
$2.59
Average daily volume
392K
Financial strength
Current ratio
3.185
Quick ratio
2.749
Long term debt to equity
205.214
Total debt to equity
226.392
Interest coverage (TTM)
-2.58%
Profitability
EBITDA (TTM)
-10.772
Gross margin (TTM)
58.64%
Net profit margin (TTM)
-26.61%
Operating margin (TTM)
-18.58%
Effective tax rate (TTM)
-0.26%
Revenue per employee (TTM)
$330,000
Management effectiveness
Return on assets (TTM)
-14.92%
Return on equity (TTM)
-113.82%
Valuation
Price to revenue (TTM)
2.527
Price to book
15.05
Price to tangible book (TTM)
15.05
Price to free cash flow (TTM)
-23.687
Free cash flow yield (TTM)
-4.22%
Free cash flow per share (TTM)
-0.321
Growth
Revenue change (TTM)
20.83%
Earnings per share change (TTM)
-10.05%
3-year revenue growth (CAGR)
10.35%
3-year earnings per share growth (CAGR)
-26.61%
Exagen News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.